Consistent with the CCK8 results, the cell proliferation increased significantly in the Si-FOXD3 group as compared to the control group, indicating that FOXD3 could inhibit the proliferation of colon cancer bone metastatic cells. This evidence concerns the gene FOXD3 and malignant colon neoplasm.